Cipla completes 100% acquisition of Inzpera Healthsciences

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹1518.00

prior close

₹1525.00

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.5%-0.4% vs market

Pharmaceuticals peers, median of 156sector-0.3%+0.4% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty 100 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.3

15m

-0.3

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1+0.5-0.4-0.3+0.4

Next day

-1.4-0.5-0.9-2.3+0.9

-1.6-0.8-0.8-1.6-0.1

-1.8-1.1-0.7-1.8-0.0

-0.4-0.6+0.2-1.6+1.2

-0.1+0.0-0.2-1.1+1.0

-1.2-0.6-0.6-1.6+0.5

15d

-1.7-0.3-1.4-1.9+0.2

+0.1+1.1-1.0-0.6+0.7

-12.2-1.2-11.0-5.5-6.7

-12.5-4.3-8.3-8.7-3.8

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Cipla Limited has completed the acquisition of 100% stake in Inzpera Healthsciences Limited on 4th December 2025, making Inzpera a wholly owned subsidiary. This follows an earlier intimation dated 3rd November 2025 about the deal.

Likely market impact

Inzpera is now a wholly owned subsidiary; expands Cipla's healthsciences portfolio and consolidates earnings.